Interstitial Lung Disease

Interstitial Lung Disease (ILD) is a group of lung diseases that affect the tissue between the air sacs (alveoli). It causes inflammation and scarring (fibrosis) in the lungs, making it hard to breathe. Think of it like scar tissue building up in the lungs.

Condition

What people with Interstitial Lung Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Home oxygen therapy for Interstitial Lung Disease?

NameHow it went

About Interstitial Lung Disease

What It Is

Interstitial lung disease (ILD) is an umbrella term for a large group of conditions that inflame or scar the lung tissue. The damage is in the thin walls around the tiny air sacs, where oxygen passes into the blood. When that tissue becomes inflamed or thick and stiff, the lungs cannot expand fully and oxygen moves into the bloodstream less easily. The main symptoms are shortness of breath, first noticed with activity such as climbing stairs, and a dry cough that does not go away. Fatigue is common. Symptoms usually start mildly and build over months or years, so people often put them down to age or fitness at first. Some people develop clubbing, a rounding and widening of the fingertips. Because ILD covers many different diseases, the specific type matters a great deal. Idiopathic pulmonary fibrosis (IPF) is the most common type and usually worsens over time. Other types can stay stable for years or improve with treatment. ILD is also different from asthma and COPD (chronic obstructive pulmonary disease), which mainly affect the airways rather than the tissue around the air sacs.

Causes & Risk Factors

Doctors group ILD by whether a cause can be found. Known causes include autoimmune conditions such as rheumatoid arthritis, scleroderma, lupus and myositis, in which the immune system attacks the lungs along with other tissues. Breathing in dusts or fibers over time can scar the lungs, as with asbestos, silica and coal dust in certain jobs. Hypersensitivity pneumonitis is an immune reaction to inhaled material such as mold or bird feathers and droppings, which may come from work, hobbies or the home. Some medicines can damage the lungs, including amiodarone (a heart rhythm medicine), nitrofurantoin (an antibiotic), methotrexate (an immune-suppressing medicine used for rheumatoid arthritis and some cancers) and certain cancer treatments, as can radiation to the chest. When no cause is found, the condition is called idiopathic. Idiopathic pulmonary fibrosis mainly affects older adults. Older age, smoking now or in the past, and a family history of pulmonary fibrosis raise the risk. Having a risk factor does not mean someone will develop ILD, and many people with ILD never had a clear exposure.

How It's Diagnosed

Diagnosis usually involves several steps. A clinician asks about symptoms, other health conditions, every medicine taken now or in the past, family history, and exposures at work, at home and through hobbies, including birds, mold and dusts. Listening to the lungs often reveals fine crackling sounds called crackles. A high-resolution computed tomography (CT) scan, a detailed X-ray scan of the chest, is the key imaging test. The pattern and location of scarring often point to a specific type. Breathing tests (pulmonary function tests) measure how much air the lungs hold and how well oxygen passes into the blood. Results are compared with what is expected for a person's age, height and sex. ILD usually pushes both values below the expected range, and these results become the baseline: a fall over time is a sign the disease is progressing. Oxygen levels may be checked at rest and during a walking test. Blood tests look for autoimmune disease. When the cause is still unclear, a bronchoscopy (a thin camera passed into the airways) or a lung biopsy may be needed. Biopsies can be taken with a freezing probe through a bronchoscope at specialist centers or through surgery. Many centers reach a final diagnosis through a team discussion among lung specialists, radiologists and pathologists, because no single test identifies every type.

Treatment Options

Treatment depends on the type of ILD and how quickly it is changing. The goals are to protect remaining lung function, slow further scarring, ease breathlessness and keep daily life as active as possible. Existing scarring generally cannot be reversed, so early treatment matters. When a cause is found, removing it comes first. That can mean avoiding the mold, birds or dust behind hypersensitivity pneumonitis, stopping a medicine that harmed the lungs, or treating an underlying autoimmune disease. Stopping smoking helps in every type. For inflammatory and autoimmune forms, corticosteroids such as prednisone and other medicines that calm the immune system, such as mycophenolate, are often used. These need regular monitoring because they lower resistance to infection. Some of these medicines, including mycophenolate and nintedanib, can harm a developing baby, so anyone who could become pregnant should discuss contraception and pregnancy plans before starting. Antifibrotic medicines slow the buildup of new scar tissue. For idiopathic pulmonary fibrosis, the options are pirfenidone (Esbriet), nintedanib (Ofev) and nerandomilast (Jascayd). Nintedanib and nerandomilast are also approved for adults with other types of lung fibrosis that keep worsening, and nintedanib for ILD linked to scleroderma. These medicines slow the decline in lung function rather than improve breathing, so their benefit shows as a slower loss over time. Stomach and bowel effects, especially diarrhea and nausea, are the most common reasons for adjusting them, and some need regular blood tests to check the liver. Supportive care makes a real difference. Pulmonary rehabilitation, a supervised program of exercise and breathing training, can improve stamina and confidence. Oxygen is prescribed when blood oxygen levels drop, at rest, during activity or at night. Vaccinations help prevent infections that can worsen breathing. For selected people with severe, progressive disease, a lung transplant can improve quality of life and survival, after an extensive evaluation and time on a waiting list.

What to Expect

The outlook varies more with ILD than with many conditions, because it depends heavily on the type. Some forms, especially when an exposure is removed or inflammation responds to treatment, stay stable for years. Idiopathic pulmonary fibrosis and other forms that continue to scar usually worsen over time, though the pace differs a lot between people and can be slowed with treatment. Regular follow-up, often every few months, tracks breathing tests, oxygen levels, symptoms and sometimes repeat scans. A steady decline across these measures is how doctors recognize progressive disease and decide whether to start or change treatment. Daily life often involves planning activity around breathlessness, pacing tasks, and for some people, using oxygen at home and when going out. Air travel may need extra oxygen. Fatigue, cough and the emotional weight of a chronic lung condition are real parts of the experience, and rehabilitation programs, support groups and palliative care teams (which focus on comfort and quality of life at any stage) can help. People with more advanced fibrosis may also develop high blood pressure in the lungs or face a higher risk of lung infections, which is part of why ongoing specialist care matters. Discussing goals and preferences early, including transplant eligibility, helps keep later decisions in the person's hands.

When to Seek Help

Arrange an appointment if you have shortness of breath with activity that is gradually getting worse, or a dry cough that lasts more than a few weeks, especially if you have an autoimmune disease, a history of dust or mold exposure, or a family history of pulmonary fibrosis. If you already have ILD, contact your care team right away if your breathing becomes noticeably worse over a few days, if you develop a fever or chest infection, or if your oxygen readings on a fingertip pulse oximeter fall below the usual range you have agreed with your care team. A sudden worsening of fibrosis, called an acute exacerbation, can be serious and needs prompt assessment. Call 911 for severe difficulty breathing, bluish lips or fingers, or new confusion or unusual sleepiness.

Questions to Ask Your Doctor

  1. 1.What type of interstitial lung disease do I have, and how confident are we in that diagnosis?
  2. 2.Is there an exposure, medicine or other condition contributing to it that we can address?
  3. 3.Is my disease stable or progressing, and which test results will tell us?
  4. 4.Would an antifibrotic or immune-suppressing medicine help in my case, and what side effects should I plan for?
  5. 5.Should I be referred to pulmonary rehabilitation, be tested for oxygen needs, or start a transplant evaluation?

Last reviewed • Oct 2026

Educational content, not medical advice.